In this issue:
Pimavanserin for negative symptoms of schizophrenia
Brain atrophy in FEP of the elderly and cognitive decline
Psychosis-risk screening adolescents within an inpatient psychiatric setting
Dopamine and glutamate in individuals at high risk for psychosis
Functional outcomes of early intervention vs regular care following two years of early intervention for psychosis
Fatal poisonings involving clozapine
How efficacious are antipsychotic drugs for schizophrenia?
Antipsychotic use is associated with greater adherence to cardiometabloic medications in patients with schizophrenia
Topiramate add-on therapy for weight reduction in persons with schizophrenia
Risk of obesity among children prescribed atypical antipsychotics
Please login below to download this issue (PDF)